Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

MiR-492 impairs the angiogenic potential of endothelial cells.

Patella F, Leucci E, Evangelista M, Parker B, Wen J, Mercatanti A, Rizzo M, Chiavacci E, Lund AH, Rainaldi G.

J Cell Mol Med. 2013 Aug;17(8):1006-15. doi: 10.1111/jcmm.12085. Epub 2013 Jun 26.

2.

miR-125a-5p impairs endothelial cell angiogenesis in aging mice via RTEF-1 downregulation.

Che P, Liu J, Shan Z, Wu R, Yao C, Cui J, Zhu X, Wang J, Burnett MS, Wang S, Wang J.

Aging Cell. 2014 Oct;13(5):926-34. doi: 10.1111/acel.12252. Epub 2014 Jul 24.

3.

Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization.

Liu CH, Sun Y, Li J, Gong Y, Tian KT, Evans LP, Morss PC, Fredrick TW, Saba NJ, Chen J.

Proc Natl Acad Sci U S A. 2015 Sep 29;112(39):12163-8. doi: 10.1073/pnas.1508426112. Epub 2015 Sep 15.

4.

Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase.

Sun HX, Zeng DY, Li RT, Pang RP, Yang H, Hu YL, Zhang Q, Jiang Y, Huang LY, Tang YB, Yan GJ, Zhou JG.

Hypertension. 2012 Dec;60(6):1407-14. doi: 10.1161/HYPERTENSIONAHA.112.197301. Epub 2012 Oct 29.

5.

MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells.

Sabatel C, Malvaux L, Bovy N, Deroanne C, Lambert V, Gonzalez ML, Colige A, Rakic JM, Noël A, Martial JA, Struman I.

PLoS One. 2011 Feb 10;6(2):e16979. doi: 10.1371/journal.pone.0016979.

6.

microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.

Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G, Fu S, Zhang Y, Feng K, Feng Y.

Eur J Cancer. 2014 Sep;50(13):2336-50. doi: 10.1016/j.ejca.2014.06.005. Epub 2014 Jul 4.

PMID:
25001183
7.

Key role of microRNA-15a in the KLF4 suppressions of proliferation and angiogenesis in endothelial and vascular smooth muscle cells.

Zheng X, Li A, Zhao L, Zhou T, Shen Q, Cui Q, Qin X.

Biochem Biophys Res Commun. 2013 Aug 9;437(4):625-31. doi: 10.1016/j.bbrc.2013.07.017. Epub 2013 Jul 15.

PMID:
23867820
8.

Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a.

Wu W, Xiao H, Laguna-Fernandez A, Villarreal G Jr, Wang KC, Geary GG, Zhang Y, Wang WC, Huang HD, Zhou J, Li YS, Chien S, Garcia-Cardena G, Shyy JY.

Circulation. 2011 Aug 2;124(5):633-41. doi: 10.1161/CIRCULATIONAHA.110.005108. Epub 2011 Jul 18.

9.

Annexin-A1 regulates microRNA-26b* and microRNA-562 to directly target NF-κB and angiogenesis in breast cancer cells.

Anbalagan D, Yap G, Yuan Y, Pandey VK, Lau WH, Arora S, Bist P, Wong JS, Sethi G, Nissom PM, Lobie PE, Lim LH.

PLoS One. 2014 Dec 23;9(12):e114507. doi: 10.1371/journal.pone.0114507. eCollection 2014.

10.

MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2.

He T, Qi F, Jia L, Wang S, Song N, Guo L, Fu Y, Luo Y.

J Pathol. 2014 Apr;232(5):499-508. doi: 10.1002/path.4324. Epub 2014 Feb 24.

PMID:
24403060
11.

Inhibition of miR-7 promotes angiogenesis in human umbilical vein endothelial cells by upregulating VEGF via KLF4.

Li YZ, Wen L, Wei X, Wang QR, Xu LW, Zhang HM, Liu WC.

Oncol Rep. 2016 Sep;36(3):1569-75. doi: 10.3892/or.2016.4912. Epub 2016 Jul 5.

PMID:
27431648
12.

CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells.

Liu GT, Huang YL, Tzeng HE, Tsai CH, Wang SW, Tang CH.

Cancer Lett. 2015 Feb 28;357(2):476-87. doi: 10.1016/j.canlet.2014.11.015. Epub 2014 Nov 13.

PMID:
25444917
13.

Antiangiogenic role of miR-361 in human umbilical vein endothelial cells: functional interaction with the peptide somatostatin.

Dal Monte M, Landi D, Martini D, Bagnoli P.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Jan;386(1):15-27. doi: 10.1007/s00210-012-0808-1. Epub 2012 Nov 6.

PMID:
23128854
14.

Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions.

Long J, Wang Y, Wang W, Chang BH, Danesh FR.

J Biol Chem. 2010 Jul 23;285(30):23457-65. doi: 10.1074/jbc.M110.136168. Epub 2010 May 25.

15.

MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.

Hartmann D, Fiedler J, Sonnenschein K, Just A, Pfanne A, Zimmer K, Remke J, Foinquinos A, Butzlaff M, Schimmel K, Maegdefessel L, Hilfiker-Kleiner D, Lachmann N, Schober A, Froese N, Heineke J, Bauersachs J, Batkai S, Thum T.

Circulation. 2016 Dec 13;134(24):1973-1990. Epub 2016 Oct 25.

PMID:
27780851
16.

Argonaute 2 promotes myeloma angiogenesis via microRNA dysregulation.

Wu S, Yu W, Qu X, Wang R, Xu J, Zhang Q, Xu J, Li J, Chen L.

J Hematol Oncol. 2014 May 7;7:40. doi: 10.1186/1756-8722-7-40.

17.

MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells.

Tabruyn SP, Hansen S, Ojeda-Fernández ML, Bovy N, Zarrabeitia R, Recio-Poveda L, Bernabéu C, Martial JA, Botella LM, Struman I.

Angiogenesis. 2013 Oct;16(4):877-87. doi: 10.1007/s10456-013-9362-9. Epub 2013 Jun 26.

18.

Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3.

Meng S, Cao J, Zhang X, Fan Y, Fang L, Wang C, Lv Z, Fu D, Li Y.

PLoS One. 2013 Jul 12;8(7):e68611. doi: 10.1371/journal.pone.0068611. Print 2013.

19.

MicroRNA-217 promotes angiogenesis of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and FOXO3A.

Zhang S, Liu L, Wang R, Tuo H, Guo Y, Yi L, Wang D, Wang J.

PLoS One. 2013 Dec 20;8(12):e83620. doi: 10.1371/journal.pone.0083620. eCollection 2013.

20.

MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A.

Urbich C, Kaluza D, Frömel T, Knau A, Bennewitz K, Boon RA, Bonauer A, Doebele C, Boeckel JN, Hergenreider E, Zeiher AM, Kroll J, Fleming I, Dimmeler S.

Blood. 2012 Feb 9;119(6):1607-16. doi: 10.1182/blood-2011-08-373886. Epub 2011 Dec 19.

Supplemental Content

Support Center